Back to search

Article

Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome

2025-04-22

Abstract excerpt

WHIM (Warts, Hypogammaglobulinemia, Infections and Myelokathexis) syndrome is an ultrarare inborn error of immunity caused by heterozygous, gain-of-function CXCR4 mutations that impede leukocyte egress from bone marrow, resulting in panleukopenia. The CXCR4 antagonist plerixafor (AMD3100, Mozobil) durably reverses panleukopenia and in most WHIM patients induces wart regression; however, its short half-life require...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
121a8da5-1116-5191-8825-e7e7dddcaecd
DOI
10.1101/2025.04.19.25325865
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM SyndromeDOI 10.1101/2025.04.19.25325865
Select a neighboring publication to make it the new centre.